Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering

Go back to Galectin Therapeutics Announces Pricing of $9.8 Million Registered Direct Offering
GALECTIN (NASDAQ: GALT) Delayed: 4.61 +0.26 (5.98%)
Previous Close $4.35    52 Week High $3.05 
Open $4.33    52 Week Low $0.49 
Day High $4.72    P/E N/A 
Day Low $4.33    EPS $-1.32 
Volume 473,483